Guidelines for the Management of Severe Traumatic Brain Injury: 2020 Update of the Decompressive Craniectomy Recommendations.

Brain Trauma Foundation Craniectomy Decompression Decompressive craniectomy Fourth edition Guideline Head injury Severe Surgery Traumatic brain injury

Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
01 09 2020
Historique:
accepted: 28 05 2020
received: 28 05 2020
pubmed: 8 8 2020
medline: 29 12 2020
entrez: 8 8 2020
Statut: ppublish

Résumé

When the fourth edition of the Brain Trauma Foundation's Guidelines for the Management of Severe Traumatic Brain Injury were finalized in late 2016, it was known that the results of the RESCUEicp (Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension) randomized controlled trial of decompressive craniectomy would be public after the guidelines were released. The guideline authors decided to proceed with publication but to update the decompressive craniectomy recommendations later in the spirit of "living guidelines," whereby topics are updated more frequently, and between new editions, when important new evidence is published. The update to the decompressive craniectomy chapter presented here integrates the findings of the RESCUEicp study as well as the recently published 12-mo outcome data from the DECRA (Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury) trial. Incorporation of these publications into the body of evidence led to the generation of 3 new level-IIA recommendations; a fourth previously presented level-IIA recommendation remains valid and has been restated. To increase the utility of the recommendations, we added a new section entitled Incorporating the Evidence into Practice. This summary of expert opinion provides important context and addresses key issues for practitioners, which are intended to help the clinician utilize the available evidence and these recommendations. The full guideline can be found at: https://braintrauma.org/guidelines/guidelines-for-the-management-of-severe-tbi-4th-ed#/.

Identifiants

pubmed: 32761068
pii: 5881627
doi: 10.1093/neuros/nyaa278
pmc: PMC7426189
doi:

Types de publication

Journal Article Practice Guideline Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

427-434

Subventions

Organisme : US Army Contracting Command
ID : W911 QY-14-C-0086
Pays : International

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© Congress of Neurological Surgeons 2020.

Références

BMJ. 2008 Feb 23;336(7641):425-9
pubmed: 18270239
Crit Care. 2009;13(6):R185
pubmed: 19930556
N Engl J Med. 2016 Sep 22;375(12):1119-30
pubmed: 27602507
Intensive Care Med. 2019 Dec;45(12):1783-1794
pubmed: 31659383
Intensive Care Med. 2020 May;46(5):919-929
pubmed: 31965267
J Neurotrauma. 2020 Mar 1;37(5):810-816
pubmed: 32027212
Acta Neurochir (Wien). 2019 Jul;161(7):1261-1274
pubmed: 31134383
Neurosurgery. 2006 Mar;58(3 Suppl):S25-46; discussion Si-iv
pubmed: 16540746
J Neurotrauma. 2005 Jun;22(6):623-8
pubmed: 15941372
Neurosurgery. 2017 Jan 01;80(1):6-15
pubmed: 27654000
J Neurosurg. 2011 May;114(5):1471-8
pubmed: 21214327
World Neurosurg. 2017 Jul;103:501-503
pubmed: 28419880
J Neurol Neurosurg Psychiatry. 2002 Sep;73 Suppl 1:i23-7
pubmed: 12185258
Trans Med Chir Soc Edinb. 1824;1:84-122
pubmed: 29583621
Br J Neurosurg. 2013 Jun;27(3):330-3
pubmed: 23530712
J Neurosurg. 2008 Oct;109(4):678-84
pubmed: 18826355
Acta Neurochir (Wien). 2013 Jul;155(7):1329-34; discussion 1334
pubmed: 23674229
J Neurotrauma. 2007 Feb;24(2):232-8
pubmed: 17375987
N Engl J Med. 2011 Apr 21;364(16):1493-502
pubmed: 21434843

Auteurs

Gregory W J Hawryluk (GWJ)

Section of Neurosurgery, GB1-Health Sciences Centre, University of Manitoba, Winnipeg, Manitoba, Canada.

Andres M Rubiano (AM)

INUB-MEDITECH Research Group, Universidad El Bosque, Bogota, Colombia.
Valle Salud Clinic, Cali, Colombia.

Annette M Totten (AM)

Oregon Health & Science University, Portland, Oregon.

Cindy O'Reilly (C)

Oregon Health & Science University, Portland, Oregon.

Jamie S Ullman (JS)

Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.

Susan L Bratton (SL)

University of Utah, Salt Lake City, Utah.

Randall Chesnut (R)

University of Washington, Seattle, Washington.

Odette A Harris (OA)

Stanford University, Stanford, California.

Niranjan Kissoon (N)

University of British Columbia, Vancouver, British Columbia.

Lori Shutter (L)

University of Pittsburgh, Pittsburgh, Pennsylvania.

Robert C Tasker (RC)

Harvard Medical School & Boston Children's Hospital, Boston, Massachusetts.

Monica S Vavilala (MS)

University of Washington, Seattle, Washington.

Jack Wilberger (J)

Drexel University, Pittsburgh, Pennsylvania.

David W Wright (DW)

Emory University, Atlanta, Georgia.

Angela Lumba-Brown (A)

Stanford University, Stanford, California.

Jamshid Ghajar (J)

Stanford University, Stanford, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH